Last reviewed · How we verify
Recurrent Persistent Urethritis
Approved treatments
- E-Mycin · Generic (originally Abbott/Lilly)
- Benzamycin · Pfizer
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Recurrent Persistent Urethritis patent landscape — cliff calendar, originator estates, attackable patents
- Recurrent Persistent Urethritis treatment landscape brief
- Recurrent Persistent Urethritis treatment updates RSS
Frequently asked questions about Recurrent Persistent Urethritis
What drugs treat Recurrent Persistent Urethritis?
Tracked treatments include E-Mycin, Benzamycin.
What is the treatment for Recurrent Persistent Urethritis?
Standard treatment for Recurrent Persistent Urethritis includes E-Mycin, Benzamycin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Recurrent Persistent Urethritis patent cliff · Recurrent Persistent Urethritis CI report
- Treatment: E-Mycin · Generic (originally Abbott/Lilly)
- Treatment: Benzamycin · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing